lestaurtinib   Click here for help

GtoPdb Ligand ID: 5672

Synonyms: CEP-701 | KT-5555 | SP924
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Lestaurtinib was identified as an inhibitor of the receptor tyrosine kinase (RTK) FLT3 (fms-related tyrosine kinase 3) with activity against leukemia cells in vitro and in vivo [2]. It has activity against other RTKs. A drug repurposing sceen for breast cancer has identified lestaurtinib as a promising agent which appears to sensitise BRCA mutant and wild type breast cancer cells to the effects of the Poly (ADP-ribose) polymerase 1 (PARP1) inhibitor AG14361 [3].
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species

lestaurtinib is commercially available from our sponsors

2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 5
Hydrogen bond donors 3
Rotatable bonds 1
Topological polar surface area 88.65
Molecular weight 439.15
XLogP 5.17
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES OCC1(O)CC2OC1(C)n1c3c4n2c2ccccc2c4c2c(c3c3c1cccc3)CNC2=O
Isomeric SMILES OC[C@@]1(O)C[C@H]2O[C@]1(C)n1c3c4n2c2ccccc2c4c2c(c3c3c1cccc3)CNC2=O
InChI InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1
InChI Key UIARLYUEJFELEN-LROUJFHJSA-N

For advanced searching click here to open chemical structure editor

Similar Ligands Click here for help
K-252a
Click here for ligand page
Targets
Calmodulin-dependent kinase II; M1 receptor; large tumor suppressor kinase 1; neurotrophic receptor tyrosine kinase 1
KT 5720
Click here for ligand page
Targets
M1 receptor; M4 receptor
KT 5823
Click here for ligand page
Targets
M1 receptor; M2 receptor
staurosporine
Click here for ligand page
Targets
TRAF2 and NCK interacting kinase; calcium/calmodulin-dependent protein kinase II beta subunit; death associated protein kinase 1; large tumor suppressor kinase 1; large tumor suppressor kinase 2; mitogen-activated protein kinase kinase 4; mitogen-activated protein kinase kinase 6; p21 (RAC1) activated kinase 2; phosphorylase kinase catalytic subunit gamma 2; protein kinase C iota; protein kinase N1; protein kinase, cAMP-dependent, catalytic, beta subunit; serine/threonine kinase 3
midostaurin
Click here for ligand page
Targets
fms related receptor tyrosine kinase 3; large tumor suppressor kinase 1; large tumor suppressor kinase 2
7-hydroxystaurosporine
Click here for ligand page
Targets
3-phosphoinositide dependent protein kinase 1; LCK proto-oncogene, Src family tyrosine kinase; checkpoint kinase 1; checkpoint kinase 2; cyclin dependent kinase 1; glycogen synthase kinase 3 beta; microtubule affinity regulating kinase 1; mitogen-activated protein kinase 14; protein kinase A; protein kinase C alpha; protein kinase C beta; protein kinase C delta; protein kinase C epsilon; protein kinase C gamma
CEP-1347
Click here for ligand page
Targets
mitogen-activated protein kinase kinase kinase 10; mitogen-activated protein kinase kinase kinase 11; mitogen-activated protein kinase kinase kinase 12; mitogen-activated protein kinase kinase kinase 9
TTT-3002
Click here for ligand page
Targets
fms related receptor tyrosine kinase 3; leucine rich repeat kinase 2
pegcantratinib
Click here for ligand page